GlycoNex Incorporation (TPEX:4168)

Taiwan · Delayed Price · Currency is TWD

26.20

0.00 (0.00%)

Jun 3, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
New Antibody Drug Department			2.54M	30.09M	5.48M	451.00K	734.00K
New Antibody Drug Department Growth			-91.55%	449.50%	1113.97%	-38.56%	-20.73%
Total			2.54M	30.09M	5.48M	451.00K	734.00K
Total Growth			-91.55%	449.50%	1113.97%	-38.56%	-20.73%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Japan			1.61M	19.28M	3.12M	-	492.00K
Japan Growth			-91.65%	517.20%	-	-	201.84%
Taiwan			933.00K	468.00K	2.35M	451.00K	242.00K
Taiwan Growth			99.36%	-80.10%	421.51%	86.36%	-67.03%
India			-	10.34M	-	-	-
Total			2.54M	30.09M	5.48M	451.00K	734.00K
Total Growth			-91.55%	449.50%	1113.97%	-38.56%	-20.73%

Source: S&P Global Market Intelligence.